Li Hua, Guo Yan-Ke, Cui Ying-Lin, Peng Tao
Department of Emergency, Henan Traditional Chinese Medicine Hospital, Zhengzhou, Henan.
Department of Nephrology, Shandong University Qilu Hospital, Jinan, Shandong, China.
Medicine (Baltimore). 2018 Dec;97(50):e13625. doi: 10.1097/MD.0000000000013625.
Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is an auto-immune and paraneoplastic encephalitis with prominent neuropsychiatric manifestations. The N-methyl-D-aspartate receptor is located in the forebrain and hippocampus and plays a role in learning and memory.
A 29-year-old female patient with anti-NMDAR encephalitis, was reported and we also reviewed the literature and summarised the characteristics of the cases.
In the present study, we reported 1 patient with anti-NMDAR encephalitis diagnosed by the detection of anti-NMDAR antibodies in serum and cerebrospinal fluid (CSF).
The patient received glucocorticoids and anti-epilepsy treatment as well as human immunoglobulin treatment.
After treatment, the patient gradually regained consciousness and was discharged after 3 months of rehabilitation. At the follow-up 2 months later, the patient had the sequelae of memory impairment and limb movement disorders.
An accurate early diagnosis and active treatment are crucial to the improvement in the prognosis of patients with anti-NMDAR receptor encephalitis.
抗N-甲基-D-天冬氨酸受体(抗NMDAR)脑炎是一种自身免疫性和副肿瘤性脑炎,具有突出的神经精神症状。N-甲基-D-天冬氨酸受体位于前脑和海马体,在学习和记忆中发挥作用。
报告了一名29岁患有抗NMDAR脑炎的女性患者,我们还查阅了文献并总结了病例特征。
在本研究中,我们报告了1例通过检测血清和脑脊液(CSF)中的抗NMDAR抗体确诊的抗NMDAR脑炎患者。
患者接受了糖皮质激素、抗癫痫治疗以及人免疫球蛋白治疗。
治疗后,患者逐渐恢复意识,经过3个月的康复后出院。2个月后的随访中,患者有记忆障碍和肢体运动障碍后遗症。
准确的早期诊断和积极治疗对抗NMDAR受体脑炎患者预后的改善至关重要。